Pfizer Inc. is in talks with Procter & Gamble Co
for a sale of the U.S. drugmaker's consumer health business, CNBC reported on Tuesday, citing sources.
Pfizer is considering options with P&G, including a joint venture, according to the CNBC report, adding that the companies were far apart on a price for the business.
Pfizer said it is evaluating potential strategic options for the unit and expects to make a decision in 2018.
GlaxoSmithKline, Reckitt Benckiser and Johnson & Johnson have all exited from the bidding process, endangering an auction Pfizer hoped would bring in as much as $20 billion
P&G said it declined to comment.
© 2021 Thomson/Reuters. All rights reserved.